ARCA biopharma competitorsClear all

ARCA biopharma's top competitors include Nightstar Therapeutics and Bioblast Pharma.
ARCA biopharma
ARCA biopharma
ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
Nightstar Therapeutics
Nightstar Therapeutics
Nightstar Therapeutics (formerly known as NightstaRx) is a clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.
Bioblast Pharma
Bioblast Pharma
Bioblast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.
Founding Date
Founding Date
2009
Founding Date
2013
Founding Date
2012
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Westminster, US HQ
Aurora, US
Westminster, US
Locations
London, GB HQ
Lexington, US
Locations
Tel Aviv-Yafo, IL HQ
Employees
Employees
1525% decrease
Employees
27
Employees
12
Valuation ($)
Valuation ($)
16.2 m
Valuation ($)
853.8 m
Valuation ($)
603.6 k
Alexa Website Rank
Alexa Website Rank
1967067
Alexa Website Rank
N/A
Alexa Website Rank
2465558

Financial

Net income
Net income
($7.9m) (FY, 2018)
Net income
($12.2m) (FY, 2016)
Net income
($4.2m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 7.2m
Total funding raised
$ 99.6m
Total funding raised
$ 4.8m
For sources of this data, please see the company profile

View company profiles

Nightstar Therapeutics
HQ
London, GB
Employees
27

Nightstar Therapeutics (formerly known as NightstaRx) is a clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.

View company
Bioblast Pharma
HQ
Tel Aviv-Yafo, IL
Employees
12

Bioblast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.

View company